Recombinant lignostilbene αβ-dioxygenase expressed in E. coli.

Spain · Medical equipment & pharmaceuticals

different companies won awards here

4,396

of the awards went to the three most frequent winners

4%

winners of the last 12 months were new here

3,791 of 4,062

buyers awarded contracts here

1,080

Based on 17,307 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)

3.7

of those lots received a single tender

42%

of the awards went to companies based in another country

1%

of the tenders came from another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.